| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |